Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 2;25(1):115.
doi: 10.1007/s10142-025-01610-4.

LSINCT5: a pivotal oncogenic long non-coding RNA in cancers

Sharanya K Sritharan  1 , Amar Harris Arifin  2 , Shamala Salvamani  3 , Rhun Yian Koh  1 , Baskaran Gunasekaran  4
Affiliations
Review

LSINCT5: a pivotal oncogenic long non-coding RNA in cancers

Sharanya K Sritharan et al. Funct Integr Genomics. .

Abstract

Long stress-induced non-coding transcript 5 (LSINCT5) is a long non-coding RNA (lncRNA) that has been demonstrated to exhibit oncogenic properties as its upregulation was found to be commonly associated with malignant clinicopathological features in various cancers. Numerous studies have reported that LSINCT5 overexpression may promote cancer progression by regulating the expression of genes that modulate important aspects of cell activity and by interfering with signalling pathways via precise mechanisms such as microRNA (miRNA) sponging, protein interactions, as well as acting as a downstream target of transcription factors. Eventually, these processes stimulate malignant behaviour such as proliferation, invasion, migration, and epithelial-mesenchymal transition (EMT). Research suggests LSINCT5 could be a useful biomarker and therapeutic target. However, understanding their complex nature and impact on physiological processes is crucial for determining their oncogenic properties and potential use in therapy. This review focuses on LSINCT5's biological functions, expression patterns, oncogenic roles, and molecular mechanisms in cancers. We further highlight the potential of LSINCT5 as a biomarker for early diagnosis and prognosis, as well as a therapeutic target in cancer therapy.

Keywords: Biomarker; Cancers; LSINCT5; LncRNA; Mechanisms; Oncogene.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

    1. Agarwal S, Melgandi W, Sonkar DR et al (2023) Epidemiological characteristics of endometrial cancer patients treated at a tertiary health center in National capital territory of India. J Cancer Res Ther 19:452. https://doi.org/10.4103/jcrt.jcrt_2029_21 - DOI - PubMed
    1. Al-Noshokaty TM, Mansour A, Abdelhamid R et al (2023) Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. Pathol - Res Pract 245:154438. https://doi.org/10.1016/j.prp.2023.154438 - DOI - PubMed
    1. Anastasiadou E, Jacob LS, Slack FJ (2018) Non-coding RNA networks in cancer. Nat Rev Cancer 18:5–18. https://doi.org/10.1038/nrc.2017.99 - DOI - PubMed
    1. Arita T, Ichikawa D, Konishi H et al (2013) Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res 33:3185–3193 - PubMed
    1. Batool SM, Yekula A, Khanna P et al (2023) The liquid biopsy consortium: challenges and opportunities for early cancer detection and monitoring. Cell Rep Med 4:101198. https://doi.org/10.1016/j.xcrm.2023.101198 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources